Mural Oncology
(MURA)
undefined
undefined%
At close: undefined
3.64
0.69%
After-hours Dec 13, 2024, 04:00 PM EST
Income Statement (Annual)
Get detailed income statement breakdowns, uncovering revenue,
expenses, and much more.
Year | FY23 | FY22 | FY21 |
Revenue | - | - | - |
Cost of Revenue | 2.57M | 1.54M | 1.47M |
Gross Profit | -2.57M | -1.54M | -1.47M |
Operating Income | -194.64M | -195.15M | -175.37M |
Interest Income | - | - | - |
Pretax Income | -195.29M | -195.15M | -175.37M |
Net Income | -207.45M | -200.03M | -175.43M |
Selling & General & Admin | 30.04M | 25.08M | 15.55M |
Research & Development | 162.03M | 170.07M | 159.82M |
Other Expenses | - | - | - |
Operating Expenses | 192.07M | 195.15M | 175.37M |
Interest Expense | - | - | - |
Selling & Marketing Expenses | -667.00K | - | - |
Cost & Expenses | 194.64M | 195.15M | 175.37M |
Income Tax | 12.16M | 4.88M | 68.00K |
Shares Outstanding (Basic) | 16.69M | 16.69M | 16.69M |
Shares Outstanding (Diluted) | 16.69M | 16.69M | 16.69M |
EPS (Basic) | -12.43 | -11.99 | -10.51 |
EPS (Diluted) | -12.43 | -11.99 | -10.51 |
EBITDA | -192.72M | -183.38M | -173.89M |
Depreciation & Amortization | 2.57M | 1.54M | 1.47M |